Becton Dickinson ramps upsyringe production amid demanddriven by China quality concerns

Becton Dickinson ramps upsyringe production amid demanddriven by China quality concerns

BD’s North Canaan plant has increased its output of syringes by more than 40% to meet the needs of U.S. healthcare customers after the FDA launched an ongoing investigation into quality issues with plastic syringes made in China.

Provided

NORTH CANAAN, Conn. — Becton, Dickinson and Company (BD) has ramped up its production of syringes at its North Canaan plant in response to quality issues with plastic syringes imported from China which were uncovered late last year by the U.S. Food and Drug Administration (FDA).

BD, a leading global medical technology company and Northwest Connecticut’s largest employer, responded to the FDA’s recommendation that consumers, healthcare providers and healthcare facilities transition away from plastic syringes made in China by increasing its domestic manufacturing of syringes at the company’s Connecticut and Nebraska facilities.

Since January, BD’s 385,000-square-foot North Canaan plant has increased its output of syringes “by over 40% to meet the needs of U.S. healthcare customers,” according to Fallon McLoughlin, director of public relations and corporate communications for the Franklin Lakes, N.J.-based company.

“BD has achieved this increase by driving operational efficiencies and relocating some production lines from other BD plants,” said McLoughin.

“We’ve added over 100 full-time associates in the last year, and currently have more than 500 full-time associates and nearly 50 contingent associates,” she said of the North Canaan site, which began its operations in 1961 with eight employees at a 25,000-square-foot facility.

BD draws its employees from throughout Northwest Connecticut and neighboring New York.

McLaughlin noted that its Connecticut plant primarily manufactures small-size syringes, and syringe and needle combination products that are “critical to the delivery of healthcare.”

Operations take place around the clock, producing more than 2 billion medical devices each year that are sold in every region worldwide.

Responding to consumer needs

In March, Eric Borin, president of BD Medication Delivery Solutions, announced a statement saying: “BD has the capacity to support additional syringe demand and is further increasing U.S. production to help ensure continuity of patient care.”

Since the initial FDA safety communication in November 2023, he noted, “BD has increased domestic manufacturing of syringes in our Nebraska and Connecticut facilities to respond to customer needs. Ensuring the safety and quality of our products is the top priority at BD.”

Borin further noted at the time that “The latest FDA safety communication does not include any BD syringes. Over our more than 125-year history, we have served the health care system’s need for essential high quality medical products, including manufacturing 2 billion additional syringes and needles to support the global pandemic response to COVID-19.”

Syringe manufacturers in China cited

In late November 2023, the FDA announced its probe into reports of leaks, breakages and other quality problems with plastic syringes manufactured in China “that are used for injecting fluids into or withdrawing fluids from, the body,” according to the health regulator.

On March 14, the FDA issued an update on warning letters sent to three entities: Jiangsu Shenli Medical Production Co. Ltd, Medline Industries, LP and Sol-Millennium Medical Inc., describing violations related to the “sale and distribution of unauthorized plastic syringes that had not been cleared or approved by the FDA,” according to a new release.

“In addition, we are actively evaluating quality issues and performance testing failures with plastic syringes made by Jiangsu Caina Medical Co Ltd., a China-based manufacturer sited in the warning letter issued to Medline Industries, LP. The FDA will take additional steps as appropriate,” the FDA stated.

In its August 16 update, the FDA continued to recommend that healthcare providers “use syringes not manufactured in China, if possible.

“At this time, glass syringes, pre-filled syringes or syringes used for topical purposes are not included. If you only have syringes manufactured in China, then continue to use them as needed until you are able to use alternative syringes and closely monitor for leaks, breakage and other problems,” the FDA announced.

In March, BD was named to Fortune’s 2024 list of America’s Most Innovative Companies, and in September, the company announced that it had been named to TIME’s 2024 list of the World’s Best Companies based on employee feedback.

BD’s operations in North Canaan have also been recognized by the U.S. Environmental Protection Agency for achieving the Energy Star Challenge for Industry for energy reduction. The site is a landfill-free site where waste is reduced, recycled or converted into energy.

Latest News

Oblong bookseller retires after 42 years on Main Street

Longtime Oblong Books employee Lisa Wright in the Millerton store on Main Street. Wright will be retiring from her position on Monday, Feb. 23, after more than 40 years at the shop.

Photo by Aly Morrissey

MILLERTON — Longtime bookseller Lisa Wright has announced her retirement from Millerton’s Oblong Books, marking the end of a 42-year run that made her the longest-serving employee of the 50-year-old shop. She was among Oblong’s first booksellers and said her departure is bittersweet. “I decided I wanted to walk away while I still loved it,” she said.

Though she is stepping away from daily life behind the counter, Wright won’t be disappearing entirely from the store. Even after her final day on Monday, Feb. 23, she plans to continue writing her signature “shelf-talkers” — handwritten notes taped to the shelves to help browsers discover new books.

Keep ReadingShow less
Cascade Creek subject to full impact study
The proposed site of Hudson River Housing’s Cascade Creek workforce housing subdivision on Route 44.
Photo by Nathan Miller

AMENIA — The Planning Board voted Wednesday to require a more detailed environmental review of the proposed 28-unit Cascade Creek workforce housing subdivision — a move that could delay the project by six to 12 months.

Under the New York State Environmental Quality Review Act, the vote — known as a positive declaration — means the board determined the project may have significant environmental impacts that require further study before it can proceed.

Keep ReadingShow less
Public debate on North East’s zoning rewrite to continue March 20
The Town of North East’s Boulevard District — a stretch of Route 44 between Millerton and the New York State border — is the town’s largest commercial zone. The proposed zoning rewrite would allow mixed-use buildings with residential apartments above ground-floor retail.
Photo by Aly Morrisey

MILLERTON — Town Board members voted last week to continue the public hearing on the town’s proposed zoning overhaul, setting a new date of Friday, March 20, at 7 p.m.

The North East Town Board also scheduled a special workshop for Tuesday, March 3, at 5 p.m. to review public comments and concerns raised during February hearings, including calls for clearer explanations of the new code’s intent and requests to expand permitted uses in commercial districts. Board members set those dates at their regular meeting Thursday, Feb. 12, which included a public hearing on the zoning rewrite along with routine department reports.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

Pine Plains surveillance controversy prompts questions in other communities

A license plate reader camera manufactured by Flock Safety captures images of drivers on Route 22 in the Town of North East.

Photo by Nathan Miller

The discovery of site markings suggesting surveillance cameras were being installed in Pine Plains prompted town officials to call an emergency meeting last week to clarify their position on the controversial technology.

The meeting, held Monday, Feb. 9, followed public outcry. Officials explained that the proposed cameras — license plate readers — were set to be installed on local roads.

Keep ReadingShow less
Local filmmaker debuts indie horror film at Millerton’s Moviehouse

Keith Boynton

Photo by Aly Morrissey

MILLERTON — Local writer and filmmaker Keith Boynton premiered his indie slasher film “The Haunted Forest” on Friday the 13th at the Millerton Moviehouse in front of a hometown crowd, marking the movie’s first public screening — the same day it debuted on Amazon Prime Video and other platforms.

With a body of work spanning decades in drama and comedy — including “The Winter House,” starring Lily Taylor — this is Boynton’s first foray into the horror genre.

Keep ReadingShow less
Former church building approved for multimedia academy

The former Presbyterian church on Main Street in Millerton will soon become the second location of Caffeine Academy, a multimedia education center originally founded in West Babylon, New York.

Photo by Nathan Miller

MILLERTON — The long-vacant Presbyterian church on Main Street is poised for a new life after the Millerton Planning Board granted approval to a new education business Wednesday, Feb. 11.

Caffeine Academy, founded by Alex That in West Babylon, New York, plans to transform the prominent building into a center for multimedia production training, offering instruction in digital music, video production and related arts.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.